bumetanide has been researched along with Extramembranous Glomerulopathy in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Kidney biopsy demonstrated a membranous nephropathy with predominant staining for C1q." | 1.38 | Membranous nephropathy with predominance of C1q: another variant of C1q nephropathy? ( Deurwaarder, ES; Hoogeveen, EK; Steenbergen, EJ; Wetzels, JF, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deurwaarder, ES | 1 |
| Steenbergen, EJ | 1 |
| Hoogeveen, EK | 1 |
| Wetzels, JF | 1 |
1 other study available for bumetanide and Extramembranous Glomerulopathy
| Article | Year |
|---|---|
Membranous nephropathy with predominance of C1q: another variant of C1q nephropathy?
Topics: Adult; Biopsy; Bumetanide; Complement C1q; Diuretics; Glomerulonephritis, Membranous; Humans; Kidney | 2012 |